Oxford BioMedica PLC (LSE:OXB) - Share price - Overview


Stock Report

Oxford BioMedica PLC OXB

Last Price
GBX695.00

Day Change
-5.60|-0.80%

As of 21/03/2019
10:49:16 GMT | GBX
Minimum 15 Minutes Delay.

Last Close700.60p
Day Range681.28 - 699.10
Mkt Cap463.30Mil
52-Wk Range511.00 - 1,062.60
Yield %-
ISINGB00BDFBVT43
Volume9,330
P/E-40.07
P/S0.11
P/CF1.44

Share Price

Total Returns 20/03/2019

 Chg (%)  
More ...
Oxford BioMedica PLC6.15 
FTSE 100 TR GBP1.58
 
Financials
201520162017
More ...
Income Statement
Turnover15.9127.7837.59
Operating Profit-14.08-11.31-7.97
Net Profit-13.02-16.64-9.02
Reported EPS-25.50-30.00-14.50
Balance Sheet
Current Assets25.7127.4436.98
Non Current Assets26.1429.5028.42
Total Assets51.8556.9465.40
Current Liabilities13.179.3221.76
Total Liabilities---
Total Equity10.8912.626.15
Cash Flow
Operating Cash Flow-16.36-5.93-1.53
Net Change in Cash-4.845.98-1.01

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
25/02/2019PurchaseDr. Lorenzo Tallarigo,M.D.644.004132,660.00
06/02/2019SaleDr. Andrew John William Heath703.002,83219,909.00
06/02/2019SaleDr. Andrew John William Heath713.009816,995.00
06/02/2019PurchaseDr. Andrew John William Heath715.009726,950.00

Company Profile

Oxford BioMedica PLC is a biopharmaceutical company based in the United Kingdom. It develops gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.

Sector

Biotechnology

Index

FTSE SmallCap ,FTSE All Share ,FTSE techMARK Focus ,FTSE techMARK All Share

Next Event 26/04/2019

Annual Report
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-5.38
Op Mrgn-0.21
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Executive OfficerMr John Dawson
Non-Executive Director, Deputy ChairmanDr. Andrew John William Heath
Executive Director, Chief Financial OfficerStuart Paynter
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.